Key Points To Watch Out For:
- Freeport shares rise 2% following Trump’s tariffs on copper.
- UnitedHealth falls 1.4% on Medicare fraud investigation.
- Novo Nordisk falls after threat of tariffs on pharmaceutical companies.
Freeport-McMoRan (FCX): Up 2% Due to Copper Tariffs
Freeport shares rose 2% in premarket trading after President Trump announced 50% tariffs on copper imports. The news pushed copper prices higher, boosting shares of U.S.-based mining companies.
Glencore (GLEN), Anglo American (UK:AAL), Zijin (2899), Jiangxi Copper (358): Fall on New Tariffs
Shares of non-U.S. copper producers declined after Trump threatened to impose steep tariffs on imported metals. The move is expected to benefit domestic miners at the expense of foreign competitors.
Novo Nordisk (NVO), Sanofi (SNY), AstraZeneca (AZN): Down After Tariff Threat
Trump proposed 200% tariffs on pharmaceutical imports, effective for 18 months. The announcement weighed on European pharma stocks. Pfizer and Eli Lilly shares remained largely unchanged.
UnitedHealth (UNH): Down 1.4% on Fraud Investigation
UnitedHealth dropped 1.4% in premarket trading after The Wall Street Journal reported that the U.S. Department of Justice’s fraud unit is investigating its Medicare billing practices.
EssilorLuxottica (EL): Up After Meta Investment
Shares of EssilorLuxottica rose in Paris following a Bloomberg report that Meta has acquired a minority stake in the eyewear giant. The two companies already collaborate on Ray-Ban smart glasses.
WPP (WPP): Down 18% After Lower Advertising Spend
WPP shares plunged 18% in London after the company revealed that clients had significantly cut advertising budgets. Peer firms Omnicom and Interpublic also declined in U.S. premarket trading.
UniCredit (UCG): Rises 3.5% After Boosting Commerzbank Stake
UniCredit gained 3.5% after converting debt into Commerzbank shares, effectively doubling its stake. The move fuels speculation about a potential merger between the Italian and German banks.
